Kercheville Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$482K Buy
4,003
+203
+5% +$23.4K 0.15% 66
2025
Q4
$415K Buy
+3,800
New +$357K 0.11% 84
2023
Q1
Sell
-17,952
Closed -$1.99M 82
2022
Q4
$1.99M Buy
+17,952
New +$1.83M 1.38% 24

Other funds holding MRK

Kercheville Advisors's MRK Position: Q1 2026 in Review

Kercheville Advisors increased its Merck (MRK) stake by 5.3% in Q1 2026, buying an estimated $23.4K and bringing the position to 4,003 shares worth $482K. The position accounts for 0.15% of the portfolio, ranked #66.

Kercheville Advisors first reported a position in MRK in Q4 2022 and has held it in 3 quarters since. The position peaked at $1.99M in Q4 2022. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Kercheville Advisors held 4,003 shares of Merck worth $482K as of Q1 2026.
  • Kercheville Advisors bought 203 Merck shares in Q1 2026, an estimated $23.4K.
  • Merck made up 0.15% of Kercheville Advisors's portfolio in Q1 2026, its #66 holding.
  • Kercheville Advisors first reported a position in Merck in Q4 2022 and has held it in 3 quarters since.
  • Kercheville Advisors's Merck position peaked at $1.99M in Q4 2022.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Kercheville Advisors's 13F filing for Q1 2026, filed 20 Apr 2026.